Agenus Inc. (AGEN)
NASDAQ: AGEN · Real-Time Price · USD
8.25
-0.11 (-1.32%)
At close: Aug 26, 2026, 4:00 PM EDT
8.38
+0.13 (1.59%)
After-hours: Aug 26, 2026, 6:02 PM EDT
Agenus Employees
Agenus had 81 employees as of December 31, 2025. The number of employees decreased by 235 or -74.37% compared to the previous year.
Employees
81
Change (1Y)
-235
Growth (1Y)
-74.37%
Revenue / Employee
$1,638,185
Profits / Employee
$1,133,272
Market Cap
371.42M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 81 | -235 | -74.37% |
| Dec 31, 2024 | 316 | -73 | -18.77% |
| Dec 31, 2023 | 389 | -144 | -27.02% |
| Dec 31, 2022 | 533 | 92 | 20.86% |
| Dec 31, 2021 | 441 | 82 | 22.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Capricor Therapeutics | 231 |
| Abeona Therapeutics | 226 |
| Lyell Immunopharma | 161 |
| Sutro Biopharma | 128 |
| Zentalis Pharmaceuticals | 106 |
| Century Therapeutics | 78 |
| Upstream Bio | 75 |
| DiaMedica Therapeutics | 35 |
AGEN News
- 8 hours ago - Agenus: No colorectal cancer recurrences observed at updated follow-up in trial - TheFly
- 8 hours ago - Agenus Announces Updated NEST Phase 2 Publication Reporting Deep Pathologic Responses and No Observed Recurrences with Neoadjuvant BOT+BAL in Resectable Colon Cancer - Business Wire
- 15 days ago - Agenus price target lowered to $25 from $30 at H.C. Wainwright - TheFly
- 19 days ago - Agenus files to sell 77.98M shares of common stock for holders - TheFly
- 19 days ago - Agenus Registration statement: Registration filing - Filings
- 20 days ago - Agenus Earnings release: Q2 2026 - Filings
- 20 days ago - Agenus Quarterly report: Q2 2026 - Filings
- 20 days ago - Agenus concentrates resources on ROBBIN, discontinues commitment to BATTMAN - TheFly